Gene medicines: The end of the beginning?

Advanced Drug Delivery Reviews

Volumn 57, Issue 5, 2005, Pages 669-673

  Rolland, Alain ^a  

^a VICAL INC   (United States)

Author keywords

Gene delivery systems; Gene medicines; Genetic vaccines; Plasmid expression systems; Plasmid pharmacokinetics; Somatic gene therapy

Indexed keywords

BIOMEDICAL ENGINEERING; DISEASES; DRUG PRODUCTS PLANTS; GENE TRANSFER; GENES; PHYSIOLOGICAL MODELS; VACCINES;

ANIMAL MODELS; BIOLOGICAL PARAMETERS; GENE DELIVERY; GENE THERAPY;

PHARMACOKINETICS;

BACTERIAL DNA; CYTOKINE; PLASMID DNA; PLASMID VECTOR; POLYLYSINE;

CELL TYPE; CPG ISLAND; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; EXPRESSION VECTOR; GENE TARGETING; HYDROPHILICITY; LIVER CELL MEMBRANE; MACROMOLECULE; NONVIRAL GENE DELIVERY SYSTEM; OPSONIZATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; TISSUE DISTRIBUTION; TRANSGENE; VASCULAR ENDOTHELIUM;

EID: 14744282879     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2005.01.002     Document Type: Note

References (22)

1. A. Rolland S. Sullivan Pharmaceutical gene delivery systems 2003 Marcel Dekker, Inc. New York, NY, USA
2. T. Friedmann The development of human gene therapy 1999 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY, USA
3. M.L. Edelstein, M.R. Abedi, J. Wixson, and R.M. Edelstein Gene therapy clinical trials worldwide, 1989-2004: an overview J. Gene Med. 6 2004 597 602
4. S. Gurunathan, D. Klinman, and R. Seder DNA vaccines: immunology, applications, and optimization Annu. Rev. Immunol. 18 2000 927 974
5. J.M. Timmerman, G. Singh, G. Hermanson, P. Hobart, D.K. Czerwinski, B. Taidi, R. Rajapaksa, C.B. Caspar, A. Van Beckhoven, and R. Levy Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma Cancer Res. 62 2002 5845 5852
6. S.T. Rottinghaus, G.A. Poland, R.M. Jacobson, L.J. Barr, and M.J. Roy Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination Vaccine 21 2003 4604 4608
7. J.E. Epstein, Y. Charoenvit, K.E. Kester, R. Wang, R. Newcomer, S. Fitzpatrick, T.L. Richie, N. Tornieporth, D.G. Heppner, C. Ockenhouse, V. Majam, C. Holland, E. Abot, H. Ganeshan, M. Berzins, T. Jones, C.N. Freydberg, J. Ng, J. Norman, D.J. Carucci, J. Cohen, and S.L. Hoffman Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A Vaccine 22 2004 1592 1603
8. R.M. Blaese, K.W. Culver, A.D. Miller, C.S. Carter, T. Fleisher, M. Clerici, G. Shearer, L. Chang, Y. Chiang, P. Tolstoshev, J.J. Greenblatt, S.A. Rosenberg, H. Klien, M. Berger, C.A. Muller, J.W. Ramsey, L. Muul, R.A. Morgan, and W.F. Anderson T lymphocyte-directed gene therapy for ADA deficiency SCID: initial trial results after 4 years Science 270 1995 475 480
9. G.J. Nabel, A. Chang, E.G. Nabel, G. Plautz, B.A. Fox, L. Huang, and S. Shu Immunotherapy of malignancy by in vivo gene transfer into tumors Hum. Gene Ther. 3 1992 399 410
10. S. Calarota, G. Bratt, S. Nordlund, J. Hinkula, A.-E. Leandersson, E. Sandstrom, and B. Wahren Cellular cytotoxic response induced by DNA vaccination in HIV-1 infected patients Lancet 351 1998 1320 1325
11. R.R. MacGregor, J.D. Boyer, K.E. Ugen, K.E. Lacy, S.J. Gluckman, M.L. Bagarazzi, M.A. Chattergoon, Y. Baine, T.J. Higgins, R.B. Ciccarelli, L.R. Coney, R.S. Ginsberg, and D.B. Weiner First human trial of DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response J. Infect. Dis. 178 1998 92 100
12. R. Wang, D.L. Doolan, T.P. Le, R.C. Hedstrom, K.M. Coonan, Y. Charoenvit, T.R. Jones, P. Hobart, M. Margalith, J. Ng, W.R. Weiss, M. Sedegah, C. de Taisne, J.A. Norman, and S.L. Hoffman Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine Science 282 1998 476 480
13. M. Cavazzana-Calvo, S. Hacein-Bey, G. de Saint Basile, F. Gross, E. Yvon, P. Nusbaum, F. Selz, C. Hue, S. Certain, J.L. Casanova, P. Bousso, F.L. Deist, and A. Fischer Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease Science 288 2000 669 672
14. A. Berns Good news for gene therapy New Engl. J. Med. 350 2004 1679 1680
15. A. Rolland Advanced gene delivery: from concepts to pharmaceutical products Drug targeting and delivery series 1999 Harwood Academic Publishers Amsteldijk, The Netherlands
16. A. Rolland Synthetic gene delivery: another quest for the Holy Grail? Curr. Opin. Investig. Drugs 2 2001 1767 1769
17. J. Merstas, and C. Hughes Of mice and not men: differences between mouse and human immunology J. Immunol. 172 2004 2731 2738
18. A. Lovatt Applications of quantitative PCR in the biosafety and genetic stability of biotechnology products Rev. Mol. Biotech. 82 2002 279 300
19. A. Quezada, J. Larson, M. French, R. Ponce, J. Perrard, R. Durland, and M. Coleman J. Pharm. Pharmacol. 56 2004 177 185
20. S. Manam, B.J. Ledwith, A.B. Barnum, P.J. Troilo, C.J. Pauley, L.B. Harper, T.G. Griffiths, Z. Niu, L. Denisova, T.T. Follmer, S.J. Pacchione, Z. Wang, C.M. Beare, W.J. Bagdon, and W.W. Nichols Plasmid DNA vaccines: tissue distribution and effects of DNA sequence, adjuvants and delivery method on integration into host DNA Intervirology 43 2000 273 281
21. T. Martin, S.E. Parker, R. Hedstrom, T. Le, S. Hoffman, J. Norman, P. Hobart, and D. Lew Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection Hum. Gene Ther. 10 1999 759 768
22. B. Ledwith, S. Manam, P. Troilo, A.B. Barnum, C.J. Pauley, T. Griffiths, L.B. Harper, C.M. Beare, W.J. Bagdon, and W.W. Nichols Plasmid DNA vaccines: investigation of integration into host cellular DNA following intramuscular injection in mice Intervirology 43 2000 258 272